Close
ACHEMA MIDDLE EAST 2026

The White House Looks For Rebates Over Drug Price Fixing

Pharma companies in the US have come under fire yet again from the White House. This is the second time in two weeks that...

Pharma Spectrum – Using Connected Drug Delivery Devices

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more...

NPRA In Malaysia Has Broadened Reference Approval Guidelines

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that...

New Pharma Legislation May Affect Europe R&D Significantly

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a...

Vetter In Rankweil Gets Permanent Manufacturer Authorization

Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in...

Global Healthcare Access Improved By Indian Pharma Cos.

As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes...

Improving Approach of UK Through Future Clinical Trials Bill

The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...